Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2026-03-03 @ 2:21 AM
Study NCT ID:
NCT02614495
Status:
COMPLETED
Last Update Posted:
2020-02-13
First Post:
2015-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma
Sponsor:
Hutchison Medipharma Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-24
First Submit QC Date:
None
Study First Post Date:
2015-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-12
Last Update Post Date:
2020-02-13
Last Update Post Date Type:
ACTUAL